Axel Mescheder
Chief Executive Officer at Cristal Delivery BV
Profile
Axel Mescheder is currently the Chief Executive & Medical Officer at Cristal Delivery BV since 2018.
Prior to this, he worked as the Director-Research & Development at MediGene AG, Chief Medical Officer at MorphoSys AG, and Chief Medical & Development Officer at Topotarget A.
He also worked as a Research Physician at the University of Cincinnati (Ohio).
Dr. Mescheder holds a doctorate degree from the University of Kiel.
Axel Mescheder active positions
| Companies | Position | Start |
|---|---|---|
Cristal Delivery BV
 Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Chief Executive Officer | 2018-11-01 |
Former positions of Axel Mescheder
| Companies | Position | End |
|---|---|---|
| TOPOTARGET A/S | Chief Tech/Sci/R&D Officer | 2012-10-30 |
| MEDIGENE AG | Chief Tech/Sci/R&D Officer | 2008-09-14 |
| MORPHOSYS AG | Chief Tech/Sci/R&D Officer | - |
| University of Cincinnati (Ohio) | Corporate Officer/Principal | - |
Training of Axel Mescheder
| University of Kiel | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MEDIGENE AG | Health Technology |
| MORPHOSYS AG | Health Technology |
| Private companies | 2 |
|---|---|
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Axel Mescheder